Haloperidol: Clinical Trials

28 trials of Haloperidol, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

28 completed. 28 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 428Completed 28

Follow Haloperidol: new trials by email Literature Review of Haloperidol trials Research Report on Haloperidol

Trials (filtered) newest first · largest first

All 28 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Haloperidol for the Treatment of Nausea and Vomiting in the ED
Haloperidol, Ondansetron - Vomiting, Nausea
Phase 4CompletedWestern Michigan University School of Medicine602021-04-012023-06-01
Treatment Strategies in CHS
Haloperidol - Cannabis Hyperemesis Syndrome
Phase 4CompletedUniversity of Calgary42020-10-132022-08-10
Haloperidol and Dexamethasone Towards Postoperative Nausea and Pain in Adult After Laparoscopy
Dexamethasone injection, Haloperidol Injection - Laparoscopy, Postoperative Nausea and Vomiting
Phase 4CompletedUniversitas Indonesia802020-01-012022-02-18
TREC-Lebanon: A Trial for Rapid Tranquilisation for Agitated Patients in the Emergency Setting
Haloperidol + Promethazine + Chlorpromazine, Haloperidol + Promethazine - Psychiatric Emergency, Aggression
Phase 4CompletedJoseph Dib1002018-08-282022-06-14
Haloperidol Versus Ondansetron for Cannabis Hyperemesis Syndrome (HaVOC)
Ondansetron 8mg, Haloperidol 0.05mg/kg, Haloperidol 0.1mg/kg - Cannabis Use Disorder
Phase 4CompletedDr. Marco L.A. Sivilotti332017-05-212024-04-03
Study of add-on Ramelteon Therapy on Sleep and Circadian Rhythm Disruption in Patients With Schizophrenia
Risperidone, Risperidone and Ramelteon, Haloperidol - Schizophrenia
Phase 4CompletedAll India Institute of Medical Sciences, Bhubaneswar1202017-05-012019-05-03
Reducing Ketamine-Induced Agitation, by Midazolam or Haloperidol Premedication After Adult Procedural Sedation
Midazolam, Haloperidol, placebo - Ketamine Induced Agitation
Phase 4CompletedTehran University of Medical Sciences1852016-07-012017-11-07
IV Haloperidol for the Treatment of Headache in the ED
Haloperidol, Placebo - Headache, Migraine Disorders
Phase 4CompletedWestern Michigan University School of Medicine1182015-10-012017-12-12
Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients
Olanzapine, Amisulpride, Risperidone - Schizophrenia, Schizophrenia and Disorders With Psychotic Features
Phase 4CompletedTechnical University of Munich212015-02-012018-10-11
Preventing Post-Operative Delirium in Patients Undergoing a Pneumonectomy, Esophagectomy or Thoracotomy
Haloperidol, Placebo - Delirium, Cognitive Impairment
Phase 4CompletedIndiana University1352013-09-012017-04-13
Baden Prevention and Reduction of Incidence of Postoperative Delirium Trial
Haloperidol, Ketamine, Haloperidol + Ketamine - Postoperative Delirium
Phase 4CompletedUniversity Hospital, Basel, Switzerland2002013-07-012019-01-23
pRophylactic halopEriDol Use for Delirium in iCu patiEnts With a High Risk for Delirium
Haloperidol 1 mg/q8h, Haloperidol 2 mg/q8h, Placebo - Delirium
Phase 4CompletedRadboud University Medical Center18002013-06-012020-11-12
Lurasidone Effects on Tissue Glutamate in Schizophrenia
Lurasidone, Haloperidol, Perphenazine - Schizophrenia, Schizoaffective Disorder
Phase 4CompletedUniversity of Texas Southwestern Medical Center352013-02-012021-03-01
Haloperidol Prophylaxis in Older Emergency Department Patients
Haloperidol, Placebo - Delirium
Phase 4CompletedAmsterdam UMC, location VUmc2422012-11-012015-11-26
Feasibility of Prophylactic Haldol to Prevent Delirium in Cancer Patients
Haldol - Stem Cell Transplant Complications, Delirium
Phase 4CompletedMichelle Weckmann172011-11-012018-05-22
Incidence of Chemotherapy-Induced Nausea and Vomiting Associated With Docetaxel-Cyclophosphamide in Early Breast Cancer.
Aprepitant - Breast Cancer
Phase 4CompletedSpanish Breast Cancer Research Group2122011-05-012023-03-07
A Comparison of Long-acting Injectable Medications for Schizophrenia
haloperidol decanoate, paliperidone palmitate - Schizophrenia, Schizoaffective Disorder
Phase 4CompletedNew York State Psychiatric Institute3112011-03-012016-10-21
Preventing ICU Subsyndromal Delirium Conversion to Delirium With Haloperidol
Haloperidol decanoate, Placebo - Subsyndromal Delirium
Phase 4CompletedNortheastern University682010-09-012017-04-14
Effects of Aripiprazole and Haloperidol on Mesolimbic System Functioning
Aripiprazole, Haloperidol, Placebo sugar pill - Psychosis, Schizophrenia
Phase 4CompletedOslo University Hospital542010-08-012014-09-12
Clinical Effectiveness of Newer Antipsychotics in Comparison With Conventional Antipsychotics in Schizophrenia
Olanzapine, Flupentixol, Quetiapine - Schizophrenia
Phase 4CompletedUniversity of Bremen1492010-02-012015-06-22

Showing 20 of 28. Sign in to see all of them.

Conditions studied

Schizophrenia (12)  ·  Psychotic Disorders (7)  ·  Delirium (5)  ·  Psychomotor Agitation (3)  ·  Nausea (2)  ·  Vomiting (2)  ·  Abdominal Pain (1)  ·  Aggression (1)  ·  Alzheimer Disease (1)  ·  Anxiety Disorders (1)  ·  Breast Neoplasms (1)  ·  Cannabinoid Hyperemesis Syndrome (1)  ·  Cognitive Dysfunction (1)  ·  Confusion (1)  ·  Depression (1)

Sponsors

New York State Psychiatric Institute (2)  ·  Western Michigan University School of Medicine (2)  ·  All India Institute of Medical Sciences, Bhubaneswar (1)  ·  Amsterdam UMC, location VUmc (1)  ·  Central South University (1)  ·  Dr. Marco L.A. Sivilotti (1)  ·  Eli Lilly and Company (1)  ·  Heinrich-Heine University, Duesseldorf (1)  ·  Indiana University (1)  ·  Janssen, LP (1)  ·  Joseph Dib (1)  ·  Mario Negri Institute for Pharmacological Research (1)  ·  Michelle Weckmann (1)  ·  Northeastern University (1)  ·  Oslo University Hospital (1)

Countries

United States (8)  ·  Germany (3)  ·  Canada (2)  ·  Netherlands (2)  ·  China (1)  ·  France (1)  ·  India (1)  ·  Indonesia (1)  ·  Iran (1)  ·  Italy (1)  ·  Lebanon (1)  ·  Norway (1)  ·  Spain (1)  ·  Switzerland (1)

Top investigators

Alberto Parabiaghi, M.D. (1)  ·  Aldy Heriwardito, Doctor (1)  ·  Alexa Hollinger, MD (1)  ·  Angelo Barbato, M.D. (1)  ·  Babar A Khan, MD, MS (1)  ·  Barbara D'Avanzo, Phil.D. (1)  ·  Carol A Tamminga, M.D. (1)  ·  Davangere Devanand, M.D. (1)  ·  George M Simpson, MD (1)  ·  Greg Schumaker, MD (1)  ·  Jessica McCoy, MD (1)  ·  John W Devlin, PharmD (1)

Results publications

PMID 38958149, PMID 11559786, PMID 14645311, PMID 14735295, PMID 16185814, PMID 17015817, PMID 17335321, PMID 17851042, PMID 18052570, PMID 18840034, PMID 19228178, PMID 1950621, PMID 21554991, PMID 21710401, PMID 21845596, PMID 21975110, PMID 22122006, PMID 22194182, PMID 24261644, PMID 24846035, PMID 25168927, PMID 25956235, PMID 26994459, PMID 27016729, PMID 27247177, PMID 27265548, PMID 2748771, PMID 29466591, PMID 29482596, PMID 30460981, PMID 30549494, PMID 30611640, PMID 30981585, PMID 32247156, PMID 32312288, PMID 32402480, PMID 32528650, PMID 33120302, PMID 33160719, PMID 3616518, PMID 3757924, PMID 39831535, PMID 8791041, PMID 9396013, PMID 9406042

NIH funding

2009 (2), R01MH055735 (1), R01MH081107 (1), R15AG034915 (1)